论文期刊

取消

高级检索

检索历史清除

首页> The British journal of dermatology> Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

导出 OA

翻译打印收藏纠错

作者： J I,Silverberg ^[1] ; D,Toth ^[2] ; T,Bieber ^[3] ; A F,Alexis ^[4] ; B E,Elewski ^[5] ; A E,Pink ^[6] ; D,Hijnen ^[7] ; T N,Jensen ^[8] ; B,Bang ^[8] ; C K,Olsen ^[8] ; A,Kurbasic ^[8] ; S,Weidinger ^[9] ; ECZTRA 3 study investigators

作者单位： Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. ^[1] XLR8 Medical Research and Probity Medical Research, Windsor, ON, Canada. ^[2] Department of Dermatology and Allergy, University Medical Center, Bonn, Germany. ^[3] Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[4] Department of Dermatology, University of Alabama, Birmingham, AL, USA. ^[5] St John's Institute of Dermatology, Guy's and St Thomas' Hospitals, London, UK. ^[6] Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands. ^[7] LEO Pharma A/S, Ballerup, Denmark. ^[8] Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. ^[9]

主题词肾上腺皮质激素类(Adrenal Cortex Hormones);抗体, 单克隆(Antibodies, Monoclonal);皮炎, 特应性(Dermatitis, Atopic);双盲法(Double-Blind Method);湿疹(Eczema);人类(Humans);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)

DOI 10.1111/bjd.19573

PMID 33000503

发布时间 2021-06-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The British journal of dermatology

The British journal of dermatology

2021年184卷3期

450-463页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷